Clinicopathologic variables (patient age at presentation, tumor size, the number of nodes involved, venous and lymphatic invasion, estrogen receptor, progesterone receptor, and human epidermal growth factor 2 receptor statuses) among rs11515 genotypes are shown in Table 1 and were compared between genotypes in the breast cancer cohort. Here, ERBB2 is linked to breast carcinoma.